Skip to main content
Search results
https://www.fda.gov/media/163792/download
about 2 years ago -
ruxolitinib amend 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration...Request for pediatric studies for ruxolitinib. We have ...
https://www.fda.gov/media/163791/download
about 2 years ago -
ruxolitinib DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration...Proposed Pediatric Study Request for ruxolitinib. These studies ...
https://www.fda.gov/media/163793/download
about 2 years ago -
ruxolitinib amend2 NDA 202192 WRITTEN REQUEST – AMENDMENT #2 Incyte Corporation...Request for pediatric studies for ruxolitinib. We have reviewed your ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ruxolitinib-chronic-graft-versus-host-disease
6 months ago -
FDA approves ruxolitinib for chronic graft-versus-host disease Share Post Linkedin...and Drug Administration approved ruxolitinib (Jakafi, Incyte ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-tivdak-tisotumab-vedotin-tftv-recurrent-or-metastatic-cervical
6 months ago -
...after chemotherapy, and Jakafi (ruxolitinib) for chronic graft-versus-host disease...after chemotherapy, and Jakafi (ruxolitinib) for chronic ...
https://www.fda.gov/media/160999/download
over 2 years ago -
Review and Evaluation: Opzelura (ruxolitinib) cream, 1.5%...(Opzelura) NDA 215309/S‐001 Opzelura (ruxolitinib) cream, 1.5% NDA/BLA ...
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older
6 months ago -
FDA has approved Opzelura (ruxolitinib) cream for the treatment of nonsegmental...Action FDA has approved Opzelura (ruxolitinib) cream for the ...
https://www.fda.gov/media/179512/download
8 months ago -
...215309 Serial No. 0084 OPZELURA® (ruxolitinib) Cream RESPONSE TO PREA NON-COMPLIANCE...September 21, 2021 for OPZELURA® (ruxolitinib) cream for the ...
https://www.fda.gov/media/165366/download
Incyte Corporation Established Name Ruxolitinib Trade Name Jakafi Pharmacologic...Evaluation NDA 202192 S-027 Jakafi (ruxolitinib) 2 TABLE OF CONTENTS ...
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ojjaara
7 months ago -
...one dose of OJJAARA, danazol or ruxolitinib. How were the trials designed? OJJAARA...receive OJJAARA 200 mg once daily or ruxolitinib adjusted dose ...
https://www.fda.gov/media/184952/download
about 1 month ago -
...immunosuppressive therapy such as ruxolitinib, alemtuzumab, anti-thymocyte globulin...5% to 30% (Zeiser et al. 2020) . Ruxolitinib is approved for ...
https://www.fda.gov/about-fda/2021-oce-annual-report/oncology-regulatory-review
1 day ago -
...mutations Y/Y 20. 9/22/2021 Jakafi (ruxolitinib) cGVHD Y/N 21. 10/12/2021 Verzenio...radioactive iodine 5. 9/22/2021 Jakafi (ruxolitinib) For chronic ...
https://www.fda.gov/media/179510/download
8 months ago -
Cosmetic Act (the Act) for Opzelura (ruxolitinib) cream, which was approved on September
https://www.fda.gov/safety/medical-product-safety-information/janus-kinase-jak-inhibitors-drug-safety-communication-fda-requires-warnings-about-increased-risk
6 months ago -
Two other JAK inhibitors, Jakafi (ruxolitinib) and Inrebic (fedratinib), are not
https://www.fda.gov/drugs/news-events-human-drugs/notable-approvals-drugs
about 2 months ago -
...12 and older 7/19/2022 Opzelura ruxolitinib FDA approves treatment for chronic
https://www.fda.gov/media/173538/download
over 3 years ago -
Brazil ruxolitinib The Food and Drug Administration approved ruxolitinib (Jakafi...12 years and older. FDA approves ruxolitinib for chronic ...
https://www.fda.gov/media/181761/download
over 3 years ago -
Brazil ruxolitinib The Food and Drug Administration approved ruxolitinib (Jakafi...12 years and older. FDA approves ruxolitinib for chronic ...
https://www.fda.gov/media/169691/download
over 3 years ago -
Brazil ruxolitinib The Food and Drug Administration approved ruxolitinib (Jakafi...12 years and older. FDA approves ruxolitinib for chronic ...
https://www.fda.gov/media/185192/download
about 1 month ago -
...refractory (SR-aGVHD) have poor outcomes. Ruxolitinib is the only drug approved for treatment...response rate including the approval of ruxolitinib ...
https://www.fda.gov/media/180575/download
over 3 years ago -
Brazil ruxolitinib The Food and Drug Administration approved ruxolitinib (Jakafi...12 years and older. FDA approves ruxolitinib for chronic ...
